MV Chandrakanth, Academic Head and Medical Oncologist at Narayana Health, shared on X:
”Metastatic RCC/ Who needs deferred nephrectomy?
Not every good responder needs surgery!
Treat first: IO–IO or IO–TKI → reassess after 3 – 6 months.
Consider deferred CN:
- Major PR / durable SD
- Low metastatic burden
- ECOG 0 – 1
- Favourable/intermediate IMDC risk
- Acceptable surgical risk
Continue systemic therapy alone:
- Early progression or bulky metastases
- Poor PS / poor IMDC risk
- High surgical risk
The unanswered question: Does deferred CN improve overall survival in the IO era?
Survival benefit remains unproven in randomized trials. Await PROBE and NORDIC-SUN phase III results.
Take-home: Treat first. Assess response. Select surgery carefully through MDT.”
You can also read:
